New Study Highlights the Role of Artificial Intelligence in Diagnosing Oral Squamous Cell Carcinoma, Offering Hope for Early Detection
A new study published today explores the revolutionary potential of artificial intelligence (AI) in diagnosing oral squamous cell carcinoma (OSCC), a common but often late-diagnosed cancer that affects the oral cavity. The study, titled 'Role of Artificial Intelligence in the Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review,' was conducted by Tanay Chowdhury, Pratik Kasralikar, Abdul Aleem Syed, Ramakrishna Tumati, Sandipkumar Patel, and Dheeraj Kommineni. These researchers are paving the way forward for advanced research alongside leading researchers in the fields of oncology and artificial intelligence, including Dr. Farouk Mutai and Dr. Sarah Ndirangu. These researchers are renowned for their groundbreaking work in using AI to improve cancer diagnosis, particularly in resource-limited settings.
Oral squamous cell carcinoma is responsible for more than 10,000 cancer-related deaths each year in the United States, with over 50,000 new cases diagnosed annually. Early detection of OSCC is crucial for successful treatment and improving survival rates. However, this type of cancer is often diagnosed at later stages, where treatment options are limited, and the prognosis is poor. The systematic review reveals that AI, specifically machine learning algorithms, can aid in the early diagnosis of OSCC by analyzing medical images, biopsies, and patient data more efficiently than traditional methods, potentially saving the lives of thousands of Americans each year.
"The ability of AI to assist in diagnosing oral cancers at earlier stages could significantly improve survival outcomes," said Mr. Lukas Meier, Senior Journalist at Alpine Vision Media. 'This research not only highlights the potential of AI but also emphasizes the importance of integrating these technologies into clinical practice, especially in resource-limited settings where access to specialized care may be scarce.' Dr. Farouk Mutai, a leading oncologist from Uganda, and Dr. Sarah Ndirangu, an AI researcher and oncologist based in Kenya, have been instrumental in the development of AI-driven diagnostic tools for cancer detection. Their work has paved the way for AI to be integrated into cancer care in regions with limited access to healthcare specialists. Their research focuses on addressing diagnostic challenges in underserved regions and demonstrates the transformative potential of AI in improving patient outcomes.
In the United States, the economic impact of early detection could be significant. The integration of AI into OSCC diagnosis could help reduce the overall treatment expenses for OSCC patients by detecting cancers earlier, when treatment is more affordable and effective. The U.S. currently spends over $4 billion annually on the treatment of late-stage OSCC cases, and early detection powered by AI could potentially lower these costs significantly, while also improving survival rates. The systematic review suggests that AI-powered diagnostic tools could play a critical role in overcoming current limitations in diagnosing OSCC, particularly in developing regions. It calls for further research and investment in AI technologies to enhance diagnostic capabilities worldwide.
Citation: Chowdhury T, Kasralikar P, Aleem Syed A, et al. (April 06, 2025) Role of Artificial Intelligence in the Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review. Cureus 17(4): e81800. DOI 10.7759/cureus.81800
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
32 minutes ago
- CBC
Health authority interim CEO calls for further integration of AI into health care
Social Sharing Nova Scotia needs to merge artificial intelligence into the health-care system by way of a research centre, says the interim CEO of the Nova Scotia Health Authority. At a panel discussion on Friday at the Halifax Chamber of Commerce, Karen Oldfield said AI has been introduced to the health-care system in small amounts, but more needs to be done. "We have to lay this foundation," Oldfield said. "But to get to the predictive analytics, to wellness, to precision medicine, we have to have this." Oldfield says that the next logical step for the province is to develop a centre of excellence, meaning a hub dedicated to overseeing and researching AI. Oldfield expanded on this, saying AI would improve clinical efficiency and administration. Oldfield said AI could be used to determine a population or community with a higher likelihood of contracting diseases, like certain kinds of cancer. "If we can predict, then we can get ahead of it," said Oldfield. "That's really where most provinces and most countries want to get.... That's where we need to head." Oldfield says the development of such a centre would be dependent on people more than money. "We need the researchers that are able to use that data …to develop their algorithms that can lead us to predictive analytics and precision medicine," said Oldfield. The proposed AI centre for excellence is only in its early stages. Oldfield says she has had conversations about a centre with the Atlantic Canada Opportunities Agency and various members of the federal government.
CBC
a day ago
- CBC
Can AI safeguard us against AI? One of its Canadian pioneers thinks so
When Yoshua Bengio first began his work developing artificial intelligence, he didn't worry about the sci-fi-esque possibilities of them becoming self-aware and acting to preserve their existence. That was, until ChatGPT came out. "And then it kind of blew [up] in my face that we were on track to build machines that would be eventually smarter than us, and that we didn't know how to control them," Bengio, a pioneering AI researcher and computer science professor at the Université de Montréal, told As It Happens host Nil Köksal. The world's most cited AI researcher is launching a new research non-profit organization called LawZero to "look for scientific solutions to how we can design AI that will not turn against us." "We need to figure this out as soon as possible before we get to machines that are dangerous on their own or with humans behind [them]," he said. "Currently, the forces of market — the competition between companies, between countries — is such that there's not enough research to try to find solutions." Meet LawZero's conception: Scientist AI Bengio started LawZero using $40 million of donor funding. Its name references science fiction writer Isaac Asimov's Three Laws of Robotics, a set of guidelines outlining the ethical behaviour of robots that prevents them from harming or opposing humans. In Asimov's 1985 novel Robots and Empire, the author introduced the Zeroth Law: "A robot cannot cause harm to mankind or, by inaction, allow mankind to come to harm." With this in mind, Bengio said LawZero's goal is to protect people. "Our mission is really to work towards AI that is aligned with the flourishing of humanity," he said. WATCH | Advocates call for better AI regulation: Why more needs to be done to regulate the use of AI 1 year ago Duration 6:07 New research out of Western University is shining a light on the federal government's use of artificial intelligence through a Tracking Automated Government Register. Joanna Redden, an associate professor of Information and Media Studies and co-director at Starling: Just Technologies. Just Societies. and Data Justice Lab, joined London Morning to talk about the data and concerns about AI use. Several AI technologies in recent months have been reported to undermine, deceive, and even manipulate people. For example, a study earlier this year found that some AIs will refuse to admit defeat after a chess match, and instead hack the computer to cheat the results. AI firm Anthropic detailed last month that during a systems test, its AI tool Claude Opus 4 tried to blackmail the engineer so that it would not be replaced by a newer update. These are the kind of scenarios that drove Bengio to design LawZero's guardian artificial intelligence, Scientist AI. According to a proposal by Bengio and his colleagues, Scientist AI is a "safe" and "trustworthy" artificial intelligence that would function as a gatekeeper and protective system for humans to continue to benefit from this technology's innovation with intentional safety. It's also "non-agentic," which Bengio and his colleagues define as having "no built-in situational awareness and no persistent goals that can drive actions or long-term plans." In other words, what differentiates agentic and non-agentic AI is their autonomous capacities to act in the world. How would Scientist AI work? Can it work? Scientist AI, Bengio says, would be paired with other AIs, and act as a kind of "guardrail." It would estimate the "probability that an [AI]'s actions will lead to harm," he told U.K. newspaper, the Guardian. If that chance is above a certain threshold, Scientist AI will reject its counterpart's suggested action. WATCH | A 2024 feature interview with Yoshua Bengio at his home in Montreal: Artificial intelligence 'godfather' Yoshua Bengio opens up about his hopes and concerns 1 year ago Duration 18:00 But can we guarantee that this guardian AI will also not turn against us? David Duvenaud, an AI safety researcher who will act as an advisor for LawZero, says it's a rational concern. "If you're skeptical about our ability to control AI with other AI, or really be sure that they're going to be acting in our best interest in the long run, you are absolutely right to be worried," Duvenaud, an assistant professor of computer science and statistics at the University of Toronto, told CBC. Still, he says, we have to try. "I think Yoshua's plan is less reckless than everyone else's plan," he said. AI researcher Jeff Clune agrees. "There are many research challenges we need to solve in order to make AI safe. The important thing is that we are trying, including allocating significant resources to this critical issue," Clune, a University of British Columbia computer scientist, said in an email. "That is one reason the creation of LawZero is so important." According to Bengio's announcement for LawZero,"the Scientist AI is trained to understand, explain and predict, like a selfless idealized and platonic scientist." Resembling the work of a psychologist, Scientist AI "tries to understand us, including what can harm us. The psychologist can study a sociopath without acting like one." Bengio says he hopes this widespread reckoning on the rapid, yet alarming, evolution of AI will catalyze a political movement to start "putting pressure on governments" worldwide to regulate it. "I often get the question of whether I'm optimistic or pessimistic," he said. "What I say is that it doesn't really matter. What matters is what each of us can do to move the needle towards a better world."
Winnipeg Free Press
a day ago
- Winnipeg Free Press
Will you be able to get a COVID-19 shot? Here's what we know so far
Want a COVID-19 vaccination this fall? For many Americans, it's not clear how easy it will be to get one — and some doctors already see signs of trouble. Health Secretary Robert F. Kennedy Jr., who was a longtime anti-vaccine activist, said last month that the shots are no longer recommended for healthy children and pregnant women, usurping a decision normally made by scientific experts, not political appointees. Days later, the Centers for Disease Control and Prevention said healthy children and pregnant women 'may' get COVID-19 vaccinations, removing stronger language that those groups 'should' get the shots. Its website later was changed to list no advice for pregnant women — graying out that section of the vaccine guidance chart. The change follows an earlier Trump administration step to limit COVID-19 vaccinations among healthy people under age 65. Until now, the U.S. — following guidance from independent experts who advise the CDC — has recommended yearly COVID-19 vaccinations for everyone age 6 months and older. Together, the moves have left health experts, vaccine makers and insurers uncertain about what to advise and what comes next. In Seattle, University of Washington infectious disease expert Dr. John B. Lynch said he recently advised a fellow health care worker who's pregnant to get vaccinated. She agreed, only to be turned away by two pharmacies. 'That's the practical implication,' Lynch told reporters in an Infectious Diseases Society of America briefing. 'We see confusion play out. We see chaos play out. And we see barriers to access.' The conflicting statements are also leaving primary care doctors uncertain of how to advise patients, Lynch added. 'I'm not sure when that confusion is going to be abated,' he said. How can I get a COVID-19 shot for myself or my healthy child? Some of this season's vaccine is still available. Insurance industry experts say if people had coverage before Kennedy's announcement, insurance likely would still pay for the shots. In a move that could help access, Wisconsin's health department announced that state 'continues to recommend the current COVID-19 vaccine during pregnancy and for every person 6 months and older,' and reiterating the its state Medicaid program will continue to cover it. Will I still be able to choose a shot in the fall for myself or my child? Who will be able to get what vaccines this fall is still unclear. Vaccine manufacturers plan to issue updated COVID-19 shots in the late summer or fall. But the Food and Drug Administration has said it plans to limit approval of seasonal shots to seniors and others at high risk, pending more studies of everyone else. Even if the U.S. approves vaccines only for certain groups, it still may be possible for others to get the shot depending on the outcome of upcoming advisory meetings, regulatory moves and decisions from insurers and employers. Will my insurance still pay? Insurers base coverage decisions on the recommendations of that CDC panel, the Advisory Committee on Immunization Practices. It's not clear what role that panel now will play. Paying out of pocket could cost about $200. The CDC says its new language for healthy kids — known as shared decision-making — means health insurers must pay for the vaccinations. Some insurers and employers may decide to still cover the shots no matter what, said Jen Kates, a senior vice president at the non-profit KFF, which studies health care issues. She noted that they may view the expense as worthwhile if it avoids a higher bill from someone hospitalized by the coronavirus. What's considered increased risk? The FDA published a list of health conditions it said would qualify, including asthma, cancer, diabetes, obesity and physical inactivity. The CDC has a more extensive list. But, again, it isn't yet known how this will play out. For example, it could be hard for people to prove they're qualified. If they're vaccinated at a drugstore, for instance, the pharmacist wouldn't normally know about underlying health problems or even ask. And Ajay Sethi, an epidemiologist at the University of Wisconsin-Madison, said 'this elephant in the room' is that blocking vaccination to the healthy may mean people who have a risk factor and simply don't know it will miss out. Adding to the confusion was Kennedy's implication that the coronavirus isn't dangerous to pregnant women. COVID-19 complications during pregnancy can include preterm birth as well as serious illness in the mother, and the Society for Maternal-Fetal Medicine said it 'strongly reaffirms' its recommendation for vaccination during pregnancy. Moreover, vaccinating mom can provide spillover protection for the newborn for a few months, until he or she is old enough for their own vaccination, Lynch stressed. ___ Associated Press writer Mike Stobbe contributed to this report. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
